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Carbon Dioxide Administration
Giannoni et al. (1) report that “dynamic CO2 administration,
elivered at an appropriate time during periodic breathing, can
lmost eliminate oscillations in end-tidal CO2 and ventilation.”
This was based on 7 volunteers and 7 patients in heart failure with
“dynamic pre-emptive CO2 ventilation.” They assert that oscilla-
tions in end-tidal carbon dioxide (CO2) drive the ventilatory
scillations in periodic breathing in heart failure, but they offer no
roof. Although end-tidal CO2 will oscillate with periodic respi-
ation, so does oxygen, and a strong case might be made that
ypoxic drive causes periodic breathing.
More than 1 century ago, Douglas and Haldane (2) showed
hat, relative to treatment, “pathological Cheyne-Stokes breathing
s abolished by the administration of either oxygen or air contain-
ng excess of CO2.” But the first priority for heart failure with
periodic breathing should be focused on the failure, although
continuous positive airway pressure improves both ventricular
function and periodic breathing (3). It makes little sense to treat
such a patient with CO2; oxygen is more focused and better-
tolerated by patients.
For a patient with only central sleep apnea, mandibular advance-
ment with a dental device is simple, better-tolerated, and much less
expensive than a dedicated computer with sensors for CO2.
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Reply
We thank Dr. Guntheroth for his interest in our proof-of-concept
report (1). Patients with heart failure of course deserve optimal
treatment for heart failure, regardless of their breathing pattern.
Our report only explored the possibility of an additional physio-
logical intervention for central sleep apnea.
Steady supplementary inspired oxygen or carbon dioxide (CO2)
have long been proposed for treatment of periodic breathing (2)
and are effective in many patients. Oxygen is attractive, already
possessing a standard clinical indication in some lung diseases, butmight be less efficacious than CO2 in stabilizing breathing (3–5).
Static CO2 therapy very effectively stabilizes breathing but inevi-
tably raises CO2 and mean ventilation and undesirably enhances
drenergic overactivity. Our study shows that, by constraining
dministration (6) to bring CO2 to the alveolus for the instant
hen hyperventilation is excessively disposing of it, a much smaller
uantity of CO2 achieves the same stabilizing effect (1). Therefore,
there is less enhancement of mean ventilation and adrenergic drive.
This work does not preclude others from doing similar work with
oxygen and, indeed, might be helpful to them.
Although many existing therapies might be effective at stabiliz-
ing ventilation and—in the case of positive airways pressure—
might also increase ejection fraction, many of our patients continue
to reject the currently available treatments, preferring to suffer from
the disease (7). This is why we are exploring dynamic alternatives.
We share Dr. Guntheroth’s passion for simple solutions that are
acceptable to patients and look forward to results of mandibular
advancement for central sleep apnea. We reassure him that our
proposed therapy does not use a CO2 sensor: we only recorded
lectrocardiogram, oxygen, CO2, and other signals because their
documentation was scientifically useful. Finally the CO2 controller
lgorithm is computationally undemanding and can be imple-
ented on a generic microprocessor costing $4.00.
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